Budesonide Clinical Trials
6 recruitingDrug
Phase 33Phase 42Phase 11
Showing 1–6 of 6 trials
Recruiting
Phase 3
Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation
Engraftment Syndrome
Henry Ford Health System110 enrolled1 locationNCT05509933
Recruiting
Phase 3
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Dr. Falk Pharma GmbH308 enrolled26 locationsNCT06596252
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Asthma
Novartis Pharmaceuticals200 enrolled62 locationsNCT05562466
Recruiting
Phase 4
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Chronic Obstructive Pulmonary Disease
Maria Joyera Rodríguez135 enrolled6 locationsNCT06334575
Recruiting
Phase 4
Diesel Exhaust Induces Glucocorticoid Resistance
Exposure to PollutionGlucocorticoid Resistance
University of British Columbia30 enrolled1 locationNCT03615742
Recruiting
Phase 1
Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS
Ain Shams University60 enrolled1 locationNCT06367881